Detalhe da pesquisa
1.
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial.
Lancet
; 403(10434): 1341-1350, 2024 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38521086
2.
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.
N Engl J Med
; 387(1): 9-20, 2022 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35665782
3.
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial.
Lancet
; 401(10390): 1773-1785, 2023 05 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37086745
4.
Pembrolizumab in combination with bevacizumab and oral cyclophosphamide in heavily pre-treated platinum-resistant ovarian cancer.
Int J Gynecol Cancer
; 33(4): 571-576, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36604119
5.
Impact of CDK4/6 Inhibitors on Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS) in the Adjuvant Setting.
Breast J
; 2023: 3614296, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37293258
6.
Dose-dense sequential adjuvant chemotherapy in the trastuzumab era: final long-term results of the Hellenic Cooperative Oncology Group Phase III HE10/05 Trial.
Br J Cancer
; 127(4): 695-703, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35610366
7.
Real-world management patterns in EGFR-mutant advanced non-small-cell lung cancer before first-line adoption of osimertinib: the REFLECT study in Greece.
Future Oncol
; 18(28): 3151-3164, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35929414
8.
Advances in Gynecological Cancers.
Int J Mol Sci
; 23(11)2022 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35682831
9.
PD-L1 Gene Polymorphisms rs822336 G>C and rs822337 T>A: Promising Prognostic Markers in Triple Negative Breast Cancer Patients
Medicina (Kaunas)
; 58(10)2022 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36295559
10.
Trastuzumab administration during pregnancy: an update.
BMC Cancer
; 21(1): 463, 2021 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33902516
11.
Germline mutations in a clinic-based series of pregnancy associated breast cancer patients.
BMC Cancer
; 21(1): 572, 2021 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34011307
12.
Randomized phase III trial on niraparib-TSR-042 (dostarlimab) versus physician's choice chemotherapy in recurrent ovarian, fallopian tube, or primary peritoneal cancer patients not candidate for platinum retreatment: NItCHE trial (MITO 33).
Int J Gynecol Cancer
; 31(10): 1369-1373, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34607820
13.
Update Overview of the Role of Angiopoietins in Lung Cancer.
Medicina (Kaunas)
; 57(11)2021 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34833409
14.
Phase 2 study of cabazitaxel as second-line treatment in patients with HER2-negative metastatic breast cancer previously treated with taxanes-a Hellenic Cooperative Oncology Group (HeCOG) Trial.
Br J Cancer
; 123(3): 355-361, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32488135
15.
Prognostic impact of stromal and intratumoral CD3, CD8 and FOXP3 in adjuvantly treated breast cancer: do they add information over stromal tumor-infiltrating lymphocyte density?
Cancer Immunol Immunother
; 69(8): 1549-1564, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32303794
16.
Lymphocytic infiltration and Chemotherapy Response Score as prognostic markers in ovarian cancer patients treated with Neoadjuvant chemotherapy.
Gynecol Oncol
; 157(3): 599-605, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32173048
17.
Supportive medication in cancer during pregnancy.
BMC Pregnancy Childbirth
; 20(1): 747, 2020 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33261562
18.
Response of an oncology unit in the midst of the COVID-19 outbreak.
J Oncol Pharm Pract
; 26(8): 1947-1952, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33092498
19.
Clinical Perspectives of ERCC1 in Bladder Cancer.
Int J Mol Sci
; 21(22)2020 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33266377
20.
Effect of induction therapy with lenalidomide, doxorubicin and dexamethasone on bone remodeling and angiogenesis in newly diagnosed multiple myeloma.
Int J Cancer
; 145(2): 559-568, 2019 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30650184